Download DANDIS Program 2015

DANDIS 2015 Program
8.30-9.20am
Registration
9:20-9:30 am
Welcome – Alan Nimmo
Opening by Prof Robyn McGuiggan, DVC and head of the JCU Cairns
Campus
9:30-10:00am
ORAL SESSION 1: Protein Aggregation – Mechanics and Drug Opportunities
S1 Invited Speaker JOHN CARVER
CHAIR: IAN MUSGRAVE
10-10.30am
Morning tea
10.30-11.10 am
ORAL SESSION 2: Protein Aggregation in Ageing
S2. Invited Speaker TILMUN GRUNE Aging, Oxidation and Protein Aggregation
11:15 -12:30 ORAL SESSION 2: FROM ABSTRACTS
CHAIR: JOHN CARVER
11:15 A NOVEL PROTEINACEOUS AGGREGATE ASSOCIATED WITH NEURONAL LOSS IN PARKINSON'S
DISEASE Benjamin Trist et al.,
11:30 COPPER(I) IS A COFACTOR FOR SPECIFIC PATHWAYS OF UBIQUITIN CONJUGATION Carlos M.
Opazo et al.,
11:45 FREE RADICALS Kochupurackal Mohanakumar, et al
12:00 DISCOVERY OF TWO DIVERGENT STRATEGIES CELLS EMPLOY TO SEQUESTER MUTANT HTT
INTO INCLUSIONS Mikhail Trubetskov et al.,
12:15 break
12:30 -1:00 pm One Minute Posters
1.00-1.45pm
Lunch (provided) and posters
1.45- 2.15 pm ORAL SESSION 3: Models and Profiles Invited Speakers and from abstracts
S3. Invited Speaker LARS ITTNER: Mouse models of Frontotemporal dementia and Amyotrophic Lateral
Sclerosis
CHAIR: GERALD MUENCH
2:20 CHARACTERISATION OF A P301S MUTANT TAU TRANSGENIC MOUSE MODEL Janet Van Eersel
2:35 MODULATION OF HIPPOCAMPAL HYPERSYNCHRONICITY Arne Ittner
2:50 UTILITY AND CHALLENGES OF WHOLE-EXOME SEQUENCING IN THE HUNT FOR
NEURODEGENERATION GENES Dobson-Stone C et al.,
3:05 LIPIDOMIC PROFILING UNCOVERS LOSS OF MYELIN BIOSYNTHETIC CAPACITY Nupur Kain et al.,
3:20 PROTEIN PHOSPHORYLATION WITHIN THE NEURONS FOLLOWING BRAIN ISCHEMIA Shohreh Majd et
al
3.20 - 3.45 pm
Afternoon tea and posters
3:45- 5:00pm ORAL SESSION 4: Potential Treatment modalities
S4: Invited Speaker GERALD MUENCH: Chronic Neuroinflammation As A Therapeutic Target – From Cell Based
Screening Assays To Animal Models Of Chronic Neuroinflammation
CHAIR LARS ITTNER
4:15 TARGETING NRF2 FOR THE THERAPEUTIC TREATMENT OF NEURODEGENERATION Liddell JR et al.,
4:30 LRRK2 Pharmacological Inhibition Abates α-Synuclein Induced Neurodegeneration João P L Daher et al
4:45 NEUROPROTECTION AGAINST PARKINSON’S DISEASE WITH NEAR INFRARED LIGHT Johnstone DM
5:00 NEUROTROPHIN REGULATION OF ALZHEIMER'S DISEASE PATHOLOGY Marion Turnbull, et al.,
5:15- 5.45pm
BEYOND INTRACELLULAR PROTEIN AGGREGATES
S5: MICHAEL LARDELLI: Alzheimer's Disease – Inconvenient Truths And Revolutionary Results
CHAIR: SCOTT SMID
6:00 PM PANEL DISCUSSION – WHAT HAS THE FAILURE OF CLINICAL TRIALS FOR ALZHEIMER’S
DISEASE TAUGHT US?
6:30 Bus departs for City and DINNER – Mondo Café Bar and Grill, 24 Esplanade, Cairns